[ClinicalTrialStartPulse](/v/clinicaltrialstartpulse) / compare

# GlaxoSmithKline vs Nanjing First Hospital, Nanjing Medical University: ClinicalTrialStartPulse comparison

**Nanjing First Hospital, Nanjing Medical University's enrollment of 612 is 1.0x GlaxoSmithKline's 610 (91st percentile). GlaxoSmithKline is dated 2026-11-03; Nanjing First Hospital, Nanjing Medical University 2026-10-29.**

Data as of 2026-11-05 · [Compiled by Zalwin](/research/clinicaltrialstartpulse) from ClinicalTrials.gov (U.S. National Library of Medicine) API v2 Copy citation

Download the newest 500 ClinicalTrialStartPulse records (CSV) — $4.99 →

Both records plus every comparable record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe

## How does GlaxoSmithKline compare to Nanjing First Hospital, Nanjing Medical University?

| Field | GlaxoSmithKline | Nanjing First Hospital, Nanjing Medical University |
|---|---|---|
| Sponsor | GlaxoSmithKline | Nanjing First Hospital, Nanjing Medical University |
| Sponsor type | Industry (pharma, biotech, medtech) | Academic and hospital |
| Study | A Study to Investigate Mocertatug Rezetecan as Maintenance Treatment for Participants With MMRp Endometrial Cancer (BEHOLD-Endometrial02) | Keverprazan-Minocycline Dual Therapy of Different Durations Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication. |
| NCT ID | NCT07684599 | NCT07904429 |
| Phase | Phase 3 | Phase 3 |
| Status | recruiting | recruiting |
| Conditions | Neoplasms, Endometrial | Helicobacter Infection |
| Intervention types | drug | drug |
| Target enrollment | 610 | 612 |
| Site countries | Canada, Japan, South Korea | China |
| Posted | 2026-07-06 | 2026-10-29 |
| Planned start | 2026-09-24 | 2026-07-15 |
| Event | Started recruiting | Newly registered study |
| Event date | 2026-09-24 | 2026-10-29 |
| Last update posted | 2026-11-03 | |
| enrollment percentile | 91st | 91st |
| Score | 100/100 | 70/100 |
| Peer rank and all 500 records (CSV) | Every comparable record ranked, with amounts, dates and scores 🔒 Click to unlock → |
| Official source URLs for every peer record | Direct links to each record at its government source 🔒 Click to unlock → |

Official records: [GlaxoSmithKline](https://clinicaltrials.gov/study/NCT07684599) · [Nanjing First Hospital, Nanjing Medical University](https://clinicaltrials.gov/study/NCT07904429)

## Get new studies in your therapeutic areas

ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.

Download all matching records (CSV) — $4.99 → [See plans](/v/clinicaltrialstartpulse#pricing)

From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.

## Often used together

- [NihBiotechGrantPulse](/v/nihbiotechgrantpulse)
- [FDAPulse](/v/fdapulse)
- [WaLobbyistEmploymentRegistrationsPulse](/v/walobbyistemploymentregistratpulse)
- [SecurityIntegratorNdaaAudit](/securityintegratorndaaaudit)
- [CoreWebVitalsPulse](/corewebvitalspulse)
- [CookieConsentPulse](/cookieconsentpulse)